TKR, the Bread & Butter
ConforMIS releases its improved iTotal G2.
(October, 2012)
Synthes's Norian XR: A Look at the Numbers
Prompted by some mainstream media finger pointing, UBM Canon's editor-at-large Brian Buntz takes a look at some of the numbers behind the controversy surrounding the Synthes Norian XR product. Buntz reports: 94.17% of adverse reports involving calcium compound bone void fillers were file
(October, 2012)
Amedica’s Implants Say Goodbye to Biofilm, Hello to Osteointegration
"We suspect it will help grow cells in the $1.5 billion interbody market segment in the US. We believe that because there’s a need this segment right now for improved technology." --Amedica pre
(October, 2012)
Brazil Outlook: Orthopaedic Trauma Devices Up and Coming
The country’s market is a relevant competitor to the United States and Europe.
(September, 2012)
Lessons Learned from Stryker Biotech Case
Although recently dropped, the DOJ case exposes risks in the physician-manufacturer relationship.
(August, 2012)
OrthoTec Europe to Tackle Regulatory and Technical Challenges
The event is being held September 12-13 in Zurich.
(August, 2012)
Teleflex to Sell OEM Orthopedics Business
Teleflex Inc. (Limerick, PA), a global provider of medical technology products, has announced that it has entered into a definitive agreement to sell its OEM orthopedics business to Tecomet for $45.2 million in cash. Financing for the transaction was arranged by Charlesbank Capital Partners, the maj
(July, 2012)
Summer 2012 Earnings from Top Ortho Companies
Company Results
(July, 2012)
DJO Global Releases OA Nano Knee Brace
  Recent statistics have revealed that nearly three of ever four Americans over the age of 40 are experiencing knee pain. DJO Global, a provider of medical devices focused on musculoskeletal health, vascular health, and pain management, has released the OA Nano knee brace. The brace, designed
(July, 2012)
Mastering Degradation: How to Work with Resorbable Materials
Resorbable materials have found a home in several key clinical areas within orthopaedics. Implants that integrate such materials offer benefits over traditional static metal implants, especially in function and strength, but their use requires careful consideration from manufacturers during every st
(July, 2012)
With Challenges Come Opportunities. Now Get to Work!
Every company faces obstacles; it’s up to you to see the potential for product breakthroughs.
(June, 2012)
OrthoTec 2012: FDA Answers on Opening the Lines of Communications with Manufacturers
  This morning attendees at OrthoTec 2012 received an insider perspective on recent agency developments, changes to FDA staff training, and developments related to the 510(k) program and the benefit-risk guidance, among other updates.   Stephanie Bechtold, scientific reviewer in the Orth
(June, 2012)
Today’s Challenge in Medtech: How Can You Grow if You Don’t Have the Talent?
Jeff Somple, president of Mack Molding’s Northern Operations (Arlington, VT), sat down with OrthoTec at the MD&M East show in Philadelphia and discussed why, despite being a growing and profitable company, there is still a struggle to attract talent into the medtech industry.
(May, 2012)
Q&A: How Orthopaedic Manufacturers Should Work with Allografts
Helen Newman, PhD, CTBS (Certified Tissue Bank Specialists) is CEO and founder of Veterinary Transplant Services Inc. (Kent, WA). Since 1989, she has been involved in tissue banking at the American Red Cross Tissue Services and the Northwest Tissue Center where she served as technical superviso
(May, 2012)
Biomedical Structures Offers New Weaving Technique
Biomedical Structures (BMS; Warwick, RI), a developer of biomedical textiles for medical devices, now offers a tapered medical textile service for tendons, ligaments, and other orthopaedic applications. The new weaving techniques allow for the creation of more lifelike structures that imitate natura
(May, 2012)
Mack Molding Forms Business Unit Dedicated to Orthopaedics
Dwalin DeBoer discusses the orthopaedic instrument conversion to disposable. Capitalizing on its significant growth in orthopaedics, Mack Molding (Arlington, VT) has formed a business unit dedicated to this sector,
(May, 2012)
Tufts University Engineers Prove Fully Biodegradable Scaffold Works
Engineers at Tufts University have proven that their biodegradable scaffold for grafting works. The silk micron-sized fibers reinforces a silk matrix and can be used to repair bone and tissue, perhaps more effectively than current autologous grafts. The engineers created the 10- to 20-µm fiber
(April, 2012)
In Pursuit of the Ultimate Implant
  There is always room for improvement, and orthopaedic implants still have a way to go in materials development. Some of these opportunities to make implants better will be discussed at this year’s OrthoTec conference in Warsaw, IN in June. When working with new materials, there are th
(April, 2012)
An Exclusive Chat with Michael Son, VP of Corentec America
Earlier this year, Korea-based Corentec Co. Ltd. announced the creation of a U.S.-based wholly owned subsidiary, Corentec America Inc. Orthotec recently had the opportunity to speak with vice president of the subsidiary, Michael Y. Son. Previously, Son has worked at a number
(April, 2012)
Surface Technologies Pave the Way for Limitless Options in Orthopaedics
Leo's Top 3: Advice for manufacturers who work with (or want to work with) plasma spray technology. It could and should be considered a porous coating.  
(April, 2012)
U.S. Bracing and Supports Market to Exceed $2.48 Billion by 2018
The market will driven by spinal orthotic devices and cold therapy.
(April, 2012)
Patient-Specific Implants Demand Automation Technologies
  Thompson As the prevalence of patient-specific surgical instruments and the number of implant procedures rise, orthopaedic manufacturers are challenged to achieve speed, volume, and accuracy requirements. Alth
(April, 2012)
OrthoTec Returns to Warsaw June 6-7
Up-to-date information about OrthoTec 2012, including registration, the list of exhibitors, travel information, and interviews with speakers at the conference.
(March, 2012)
Orthopaedics Largest Segment of U.S. Implant Market, to Hit $29.4 Billion
    With an anticipated 8.8% annual growth rate, the orthopaedic implant market is expected to reach $29.4 billion in 2015, according to a recent report from The Freedonia Group Inc. (Cleveland). Growth for this segment is attributed to improvements that affect safety and durability. How
(March, 2012)
Using Allograft Tissue to Improve R&D and Preclinical Trial Outcomes for Implants
Implants that are used clinically in conjunction with allograft should also be tested and pretrialed with allograft tissue.
(March, 2012)
TKR, the Bread & Butter
ConforMIS releases its improved iTotal G2.
(October, 2012)
Synthes's Norian XR: A Look at the Numbers
Prompted by some mainstream media finger pointing, UBM Canon's editor-at-large Brian Buntz takes a look at some of the numbers behind the controversy surrounding the Synthes Norian XR product. Buntz reports: 94.17% of adverse reports involving calcium compound bone void fillers were file
(October, 2012)
Amedica’s Implants Say Goodbye to Biofilm, Hello to Osteointegration
"We suspect it will help grow cells in the $1.5 billion interbody market segment in the US. We believe that because there’s a need this segment right now for improved technology." --Amedica pre
(October, 2012)
Brazil Outlook: Orthopaedic Trauma Devices Up and Coming
The country’s market is a relevant competitor to the United States and Europe.
(September, 2012)
Lessons Learned from Stryker Biotech Case
Although recently dropped, the DOJ case exposes risks in the physician-manufacturer relationship.
(August, 2012)
OrthoTec Europe to Tackle Regulatory and Technical Challenges
The event is being held September 12-13 in Zurich.
(August, 2012)
Teleflex to Sell OEM Orthopedics Business
Teleflex Inc. (Limerick, PA), a global provider of medical technology products, has announced that it has entered into a definitive agreement to sell its OEM orthopedics business to Tecomet for $45.2 million in cash. Financing for the transaction was arranged by Charlesbank Capital Partners, the maj
(July, 2012)
Summer 2012 Earnings from Top Ortho Companies
Company Results
(July, 2012)
DJO Global Releases OA Nano Knee Brace
  Recent statistics have revealed that nearly three of ever four Americans over the age of 40 are experiencing knee pain. DJO Global, a provider of medical devices focused on musculoskeletal health, vascular health, and pain management, has released the OA Nano knee brace. The brace, designed
(July, 2012)
Mastering Degradation: How to Work with Resorbable Materials
Resorbable materials have found a home in several key clinical areas within orthopaedics. Implants that integrate such materials offer benefits over traditional static metal implants, especially in function and strength, but their use requires careful consideration from manufacturers during every st
(July, 2012)
With Challenges Come Opportunities. Now Get to Work!
Every company faces obstacles; it’s up to you to see the potential for product breakthroughs.
(June, 2012)
OrthoTec 2012: FDA Answers on Opening the Lines of Communications with Manufacturers
  This morning attendees at OrthoTec 2012 received an insider perspective on recent agency developments, changes to FDA staff training, and developments related to the 510(k) program and the benefit-risk guidance, among other updates.   Stephanie Bechtold, scientific reviewer in the Orth
(June, 2012)
Today’s Challenge in Medtech: How Can You Grow if You Don’t Have the Talent?
Jeff Somple, president of Mack Molding’s Northern Operations (Arlington, VT), sat down with OrthoTec at the MD&M East show in Philadelphia and discussed why, despite being a growing and profitable company, there is still a struggle to attract talent into the medtech industry.
(May, 2012)
Q&A: How Orthopaedic Manufacturers Should Work with Allografts
Helen Newman, PhD, CTBS (Certified Tissue Bank Specialists) is CEO and founder of Veterinary Transplant Services Inc. (Kent, WA). Since 1989, she has been involved in tissue banking at the American Red Cross Tissue Services and the Northwest Tissue Center where she served as technical superviso
(May, 2012)
Biomedical Structures Offers New Weaving Technique
Biomedical Structures (BMS; Warwick, RI), a developer of biomedical textiles for medical devices, now offers a tapered medical textile service for tendons, ligaments, and other orthopaedic applications. The new weaving techniques allow for the creation of more lifelike structures that imitate natura
(May, 2012)
Mack Molding Forms Business Unit Dedicated to Orthopaedics
Dwalin DeBoer discusses the orthopaedic instrument conversion to disposable. Capitalizing on its significant growth in orthopaedics, Mack Molding (Arlington, VT) has formed a business unit dedicated to this sector,
(May, 2012)
Tufts University Engineers Prove Fully Biodegradable Scaffold Works
Engineers at Tufts University have proven that their biodegradable scaffold for grafting works. The silk micron-sized fibers reinforces a silk matrix and can be used to repair bone and tissue, perhaps more effectively than current autologous grafts. The engineers created the 10- to 20-µm fiber
(April, 2012)
In Pursuit of the Ultimate Implant
  There is always room for improvement, and orthopaedic implants still have a way to go in materials development. Some of these opportunities to make implants better will be discussed at this year’s OrthoTec conference in Warsaw, IN in June. When working with new materials, there are th
(April, 2012)
An Exclusive Chat with Michael Son, VP of Corentec America
Earlier this year, Korea-based Corentec Co. Ltd. announced the creation of a U.S.-based wholly owned subsidiary, Corentec America Inc. Orthotec recently had the opportunity to speak with vice president of the subsidiary, Michael Y. Son. Previously, Son has worked at a number
(April, 2012)
Surface Technologies Pave the Way for Limitless Options in Orthopaedics
Leo's Top 3: Advice for manufacturers who work with (or want to work with) plasma spray technology. It could and should be considered a porous coating.  
(April, 2012)
U.S. Bracing and Supports Market to Exceed $2.48 Billion by 2018
The market will driven by spinal orthotic devices and cold therapy.
(April, 2012)
Patient-Specific Implants Demand Automation Technologies
  Thompson As the prevalence of patient-specific surgical instruments and the number of implant procedures rise, orthopaedic manufacturers are challenged to achieve speed, volume, and accuracy requirements. Alth
(April, 2012)
OrthoTec Returns to Warsaw June 6-7
Up-to-date information about OrthoTec 2012, including registration, the list of exhibitors, travel information, and interviews with speakers at the conference.
(March, 2012)
Orthopaedics Largest Segment of U.S. Implant Market, to Hit $29.4 Billion
    With an anticipated 8.8% annual growth rate, the orthopaedic implant market is expected to reach $29.4 billion in 2015, according to a recent report from The Freedonia Group Inc. (Cleveland). Growth for this segment is attributed to improvements that affect safety and durability. How
(March, 2012)
Using Allograft Tissue to Improve R&D and Preclinical Trial Outcomes for Implants
Implants that are used clinically in conjunction with allograft should also be tested and pretrialed with allograft tissue.
(March, 2012)